**Author details**

Branislava Medić Brkić1 \*, Bojan Stopić2 , Katarina Savić Vujović1 , Nevena Divac1 , Sonja Vučković1 , Radan Stojanović1 , Dragana Srebro1 , Miloš Basailović1 and Milica Prostran1

1 Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, Serbia

2 Department of Nephrology, University Medical Center Zvezdara, Belgrade, Serbia

\*Address all correspondence to: brankicamedic@gmail.com

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

*Pharmacotherapy of Rare Diseases in Serbia: The Current State of Art DOI: http://dx.doi.org/10.5772/intechopen.91262*
